<p>(<b>a–c</b>) OVCA 420, OVCA 432, and SKOV3 cell lines were treated with 20 ng/mL TGFβ for 24 hours and subjected to flow cytometry analysis. Distributions of cells in the three phases of the cell cycle are represented by mean percentages +/− SEM. Statistical significance represents a difference between number of cells in each cycle between treated and untreated and represented with * for an increase of treated cells compared to untreated; <sup>#</sup>represents decrease of treated cells compared to untreated; p≤0.05 (<b>d</b>) Western blot analysis of the three ovarian cancer cell lines probed for cell cycle proteins p21 and CDC2. Actin was used as a loading control. (<b>e–f</b>) Proliferation assay performed using BrdU incorporation in ...
Abstract Background The cellular tumor protein p53 (TP53) is a tumor suppressor gene that is frequen...
<p>Ovarian cancer cells were serum starved for 24 hours and treated for an additional 24 hours with ...
<p>Cell cycle distribution of control and AQHAR-treated U2OS (A and C) and TIG-3 (B and D) cells are...
<p>(<b>a</b>) Western blot analysis of ovarian cancer cell lines demonstrating their p53 status. Act...
<p>A, Panels depict confocal micrographs of different ovarian cancer cell lines (as specified) immun...
<p>(A) Signature of chemokine ligands and (B) chemokine receptors in human ovarian cancer cell lines...
<p>(A) Cell cycle analysis of 3T3 and 3T3BXB-ER cells. Exponentially growing cells were left untreat...
<p>HEY (A) and SKOV3 (B) cell lines were treated with CFG 3 mg/ml for 24 h and the cell cycle distri...
<p>Effect of TGFβ on cell cycle progression. All cells were synchronised overnight in serum free med...
<p>(A) Flow cytometry analysis of the time-dependent changes in cell cycle distribution of A2780 cel...
<p>(A) Identification of SP cells in established human ovarian cancer cell lines. SKOV3 and A224 cel...
<p>(<b>a</b>) Western blot analysis of stable cell lines to knockdown of p53 by shRNA plasmid or exp...
<p>HCT116 and p53KO cells were incubated in 15 μM IGG, 30 μM IGG or vehicle control for either 8 or ...
<p>(<b>a</b>) OVCA 420 (p53 wild-type), OVCA 432 (p53 mutant), and SKOV3 (null p53) cells were treat...
<p>Huh7 and Hep3B cells were treated with PP (0, 50 or 100 µg/ml) for 48 hr, harvested and subjected...
Abstract Background The cellular tumor protein p53 (TP53) is a tumor suppressor gene that is frequen...
<p>Ovarian cancer cells were serum starved for 24 hours and treated for an additional 24 hours with ...
<p>Cell cycle distribution of control and AQHAR-treated U2OS (A and C) and TIG-3 (B and D) cells are...
<p>(<b>a</b>) Western blot analysis of ovarian cancer cell lines demonstrating their p53 status. Act...
<p>A, Panels depict confocal micrographs of different ovarian cancer cell lines (as specified) immun...
<p>(A) Signature of chemokine ligands and (B) chemokine receptors in human ovarian cancer cell lines...
<p>(A) Cell cycle analysis of 3T3 and 3T3BXB-ER cells. Exponentially growing cells were left untreat...
<p>HEY (A) and SKOV3 (B) cell lines were treated with CFG 3 mg/ml for 24 h and the cell cycle distri...
<p>Effect of TGFβ on cell cycle progression. All cells were synchronised overnight in serum free med...
<p>(A) Flow cytometry analysis of the time-dependent changes in cell cycle distribution of A2780 cel...
<p>(A) Identification of SP cells in established human ovarian cancer cell lines. SKOV3 and A224 cel...
<p>(<b>a</b>) Western blot analysis of stable cell lines to knockdown of p53 by shRNA plasmid or exp...
<p>HCT116 and p53KO cells were incubated in 15 μM IGG, 30 μM IGG or vehicle control for either 8 or ...
<p>(<b>a</b>) OVCA 420 (p53 wild-type), OVCA 432 (p53 mutant), and SKOV3 (null p53) cells were treat...
<p>Huh7 and Hep3B cells were treated with PP (0, 50 or 100 µg/ml) for 48 hr, harvested and subjected...
Abstract Background The cellular tumor protein p53 (TP53) is a tumor suppressor gene that is frequen...
<p>Ovarian cancer cells were serum starved for 24 hours and treated for an additional 24 hours with ...
<p>Cell cycle distribution of control and AQHAR-treated U2OS (A and C) and TIG-3 (B and D) cells are...